Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 370

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 370
---
 on translating the opening net assets at opening rate and the results
of overseas operations at actual rate are recognised in other comprehensive income and accumulated in the foreign exchange reserve.

Exchange differences
recognised in the profit or loss of Group entities on the translation of long-term monetary items forming part of the Group’s net
investment in the overseas operation concerned are reclassified to other comprehensive income and accumulated in the foreign exchange
reserve on consolidation.

On disposal of a foreign
operation, the cumulative exchange differences recognised in the foreign exchange reserve relating to that operation up to the date of
disposal are transferred to the consolidated statement of comprehensive income as part of the gain or loss on disposal.

Financial assets and liabilities

Assets at amortised
cost

The Group does not have
any financial assets which it would classify as fair value through profit or loss. Therefore, all financial assets are classed as assets
at amortised cost as defined below.

These assets are non-derivative
financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision
of goods and services to customers (e.g., trade receivables), but also incorporate other types of contractual monetary asset. They are
initially recognised at fair value plus transaction costs that are directly attributable to their acquisition or issue and are subsequently
carried at amortised cost using the effective interest rate method, less provision for impairment.

For impairment provisions,
the Group applies the IFRS 9 simplified approach to measure expected credit losses using a lifetime expected credit loss provision for
trade receivables to measure expected credit losses on a collective basis. Trade receivables are grouped based on a similar credit risk
and ageing.

The expected loss rates
are based on the Group’s historic credit losses experienced over the three-year period prior to the period end. The historic loss
rates are then adjusted for current and forward-looking information on macroeconomic factors.

The Group’s assets
at amortised costs comprise trade and other receivables and cash and cash equivalents in the consolidated statement of financial position.

Cash and cash equivalents
include cash in hand, deposits held at call with original maturities of three months or less.

| F-35 |

| 1 | Accounting policies (continued) |

Financial liabilities

The Group classifies
its financial liabilities into one of two categories, depending on the purpose for which the liability was acquired.

Fair value through
profit and loss (‘FVTPL’)

The Group has outstanding
warrants in the ordinary